EX-12.1 3 a17-10291_1ex12d1.htm EX-12.1

EXHIBIT- 12.1

 

Corvus Pharmaceuticals, Inc.

 

STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND PREFERRED SHARE DIVIDENDS

 

(In Thousands)

 

 

 

Years Ended December 31,

 

 

 

2016

 

2015

 

2014

 

 

 

 

 

 

 

 

 

Fixed charges:

 

 

 

 

 

 

 

Interest expense

 

$

—

 

$

—

 

$

—

 

Interest component of rentals (1)

 

193

 

115

 

—

 

Total Fixed Charges

 

193

 

115

 

—

 

 

 

 

 

 

 

 

 

Earnings available for fixed charges:

 

 

 

 

 

 

 

Pre-tax income (loss) from continuing operations

 

(36,375

)

(31,335

)

(161

)

Add: Fixed Charges

 

193

 

115

 

—

 

Earnings (deficiency of earnings) available to cover fixed charges

 

$

(36,182

)

$

(31,220

)

$

(161

)

Ratio of earnings to fixed charges(2)

 

N/A

 

N/A

 

N/A

 

 

(1)    One third of rent expense was included in the calculation as it is a reasonable approximation of the interest factor.

(2)    Our earnings were inadequate to cover fixed charges for the years ended December 31, 2016, 2015 and 2014.